Little is known about the cost associated with recruitment of men into prostate cancer screening. This manuscript describes cost in terms of dollar cost and cost effectiveness for 1030 men (70% African American) in...
Garnick discussed the early treatment of metastatic prostate cancer, total androgen blockade, and the cost of 1 year of flutamide therapy. He stated that 165 000 new cases of prostate cancer are expected to be diagnosed in the United States in 1993, with 25% of patients presenting with stage...
The PHI strategy demonstrated dominance over the PSA strategy regardless of what WTP threshold we use. Conclusions A PHI-based screening strategy may be more cost-effective than a PSA-based strategy for prostate cancer detection in Chinese men. These results support consideration of a PHI-based ...
SESSION II CANCERPCN8 THE COST-EFFECTIVENESS OF PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER DETECTION Author links open overlay panelT Tencer, JW HayShow more Add to Mendeley Share Cite https://doi.org/10.1016/S1098-3015(10)62914-2Get rights and content...
Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs. cost-effectivenesscyclooxygenase-2 inhibitorsdecision analysisnonsteroidal anti-inflammatory drugsscreeningColorectal cancer is the second leading cause of cancer-... Ladabaum,Uri - 《Expert Review of Pha...
For all four screening tests, the median cash price was greater than the median negotiated price by an average of 27%.Conclusions:For common cancer screening tests, the distribution of hospital prices is wider than the actual prices reflected in claims data for the same screening services. ...
The change in social spending when the screening rate improves by 1.5 to 3 times was computed using the system model. Results: When the screening cost and its accuracy are constant, the reduction effect of medical cost is found only in the male gastric cancer. In other five cancers, medical...
transrectal ultrasound (TRUS), prostate specific antigen (PSA) and age-related PSA values, gland-volume-adjusted PSA levels, and longitudinal PSA changes were analyzed to identify their cost-effectiveness as prognostic indicators in screening, biopsy, and follow-up of patients with prostate cancer. ...
One additional cancer was detected be- yond the 171 cancers noted in our previous report de- scribing their characteristic^.'^The format for data analysis was structured to ad- dress the clinical sequence of screening and biopsy de- cisions.The screening choices considered were absolute PSA level...
Tobias Nordström, MD, on the evolving landscape of prostate cancer screening Vikram Narayan, MD, on the importance of tailoring patient communication Scott Tagawa, MD, on the mechanism of action for 177Lu-TLX591 in mCRPC Top 10 Urology Times videos of 2024 ...